Company / Current Liabilities per Share
Inhibikase Therapeutics, Inc. Current Liabilities per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.60
FY2024
5-year range
$0.15 / $0.81
FY2021-FY2024
Trend
-25.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.15 to $0.60 over the past 2 years.
Based on SEC 10-K filings.
0.60 in FY2024 with a 3-year CAGR of +14.4%.
Increased from $0.15 to $0.60 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 25.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.60 | -25.9% |
| FY2023 | $0.81 | +454.1% |
| FY2022 | $0.15 | -63.6% |
| FY2021 | $0.40 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026